Literature DB >> 8910850

Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis.

S Takeda1, K Ishthara, Y Wakui, S Amagaya, M Maruno, T Akao, K Kobashi.   

Abstract

To clarify the metabolic fate of glycyrrhizin when orally ingested, we investigated the bioavailability of glycyrrhetic acid, the aglycone of glycyrrhizin, after intravenous or oral administration of glycyrrhetic acid (5.7 mg kg-1, equimolar to glycyrrhizin) or glycyrrhizin (10 mg kg-1) at a therapeutic dose in rat. Plasma concentration of glycyrrhetic acid rapidly decreased after its intravenous administration, with AUC of 9200 +/- 1050 ng h mL-1 and MRT of 1.1 +/- 0.2 h. The AUC and MRT values after oral administration were 10600 +/- 1090 ng h mL-1 and 9.3 +/- 0.6 h, respectively. After oral administration of glycyrrhizin, the parent compound was not detectable in plasma at any time, but glycyrrhetic acid was detected at a considerable concentration with AUC of 11700 +/- 1580 ng h mL-1 and MRT of 19.9 +/- 1.3 h, while glycyrrhetic acid was not detected in plasma of germ-free rats at 12 h after oral administration of glycyrrhizin. The AUC value of glycyrrhetic acid after oral administration of glycyrrhizin was comparable with those after intravenous and oral administration of glycyrrhetic acid, indicating a complete biotransformation of glycyrrhizin to glycyrrhetic acid by intestinal bacteria and a complete absorption of the resulting glycyrrhetic acid from intestine. Plasma glycyrrhizin rapidly decreased and disappeared in 2 h after intravenous administration. AUC and MRT values were 2410 +/- 125 micrograms min mL-1 and 29.8 +/- 0.5 min, respectively. Plasma concentration of glycyrrhetic acid showed two peaks a small peak at 30 min and a large peak at 11.4 h, after intravenous administration of glycyrrhizin, with an AUC of 15400 +/- 2620 ng h L-1 and an MRT of 18.8 +/- 1.0 h. The plasma concentration profile of the latter large peak was similar to that of glycyrrhetic acid after oral administration of glycyrrhizin, which slowly appeared and declined. The difference of MRT values (19.9 and 9.3 h) for plasma glycyrrhetic acid after oral administration of glycyrrhizin and glycyrrhetic acid suggests the slow conversion of glycyrrhizin into glycyrrhetic acid in the intestine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910850     DOI: 10.1111/j.2042-7158.1996.tb05998.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  35 in total

Review 1.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

2.  [Glycyrrhetinic acid selectively inhibits proliferation of hepatocellular carcinoma cells in vitro].

Authors:  Yun-Qi Zhang; Yun Cai; Yuan Liu; Bo-Xin Zhao; Guo-Feng Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-04-20

3.  Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation.

Authors:  Tingting Yan; Hong Wang; Lijuan Cao; Qiong Wang; Shogo Takahashi; Tomoki Yagai; Guolin Li; Kristopher W Krausz; Guangji Wang; Frank J Gonzalez; Haiping Hao
Journal:  Drug Metab Dispos       Date:  2018-06-29       Impact factor: 3.922

4.  Re-evaluation of Quillaia extract (E 999) as a food additive and safety of the proposed extension of use.

Authors:  Maged Younes; Gabriele Aquilina; Laurence Castle; Karl-Heinz Engel; Paul Fowler; Maria Jose Frutos Fernandez; Peter Fürst; Rainer Gürtler; Ursula Gundert-Remy; Trine Husøy; Wim Mennes; Agneta Oskarsson; Romina Shah; Ine Waalkens-Berendsen; Detlef Wölfle; Polly Boon; Claude Lambré; Paul Tobback; Matthew Wright; Ana Maria Rincon; Camilla Smeraldi; Alexandra Tard; Peter Moldeus
Journal:  EFSA J       Date:  2019-03-06

5.  Murine metabolism and absorption of lancemaside A, an active compound in the roots of Codonopsis lanceolata.

Authors:  Noriko Komoto; Makoto Ichikawa; Sanae Ohta; Daisuke Nakano; Takeshi Nishihama; Mitsuyasu Ushijima; Yukihiro Kodera; Minoru Hayama; Osamu Shirota; Setsuko Sekita; Masanori Kuroyanagi
Journal:  J Nat Med       Date:  2010-04-10       Impact factor: 2.343

6.  Kakkalide and its metabolite irisolidone ameliorate carrageenan-induced inflammation in mice by inhibiting NF-κB pathway.

Authors:  Sung-Won Min; Young-Jun Park; Dong-Hyun Kim
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

7.  Evaluation of the safety and efficacy of Glycyrrhiza uralensis root extracts produced using artificial hydroponic-field hybrid cultivation systems II: comparison of serum concentration of glycyrrhetinic acid serum concentration in mice.

Authors:  Mitsuhiko Nose; Kazuma Yamanaka; Shinsuke Hisaka; Takayuki Inui; Noriaki Kawano; Shigeki Hayashi; Atsuyuki Hishida; Hiroyuki Fuchino; Nobuo Kawahara; Kayo Yoshimatsu
Journal:  J Nat Med       Date:  2019-04-26       Impact factor: 2.343

8.  Effect of glycyrrhizin on the activity of CYP3A enzyme in humans.

Authors:  Jiang-Hua Tu; Yi-Jing He; Yao Chen; Lan Fan; Wei Zhang; Zhi-Rong Tan; Yuan-Fei Huang; Dong Guo; Dong-Li Hu; Dan Wang
Journal:  Eur J Clin Pharmacol       Date:  2010-04-15       Impact factor: 2.953

9.  Glycyrrhizin Protects against Acetaminophen-Induced Acute Liver Injury via Alleviating Tumor Necrosis Factor α-Mediated Apoptosis.

Authors:  Tingting Yan; Hong Wang; Min Zhao; Tomoki Yagai; Yingying Chai; Kristopher W Krausz; Cen Xie; Xuefang Cheng; Jun Zhang; Yuan Che; Feiyan Li; Yuzheng Wu; Chad N Brocker; Frank J Gonzalez; Guangji Wang; Haiping Hao
Journal:  Drug Metab Dispos       Date:  2016-03-10       Impact factor: 3.922

10.  In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.

Authors:  T Imai; M Sakai; H Ohtake; H Azuma; M Otagiri
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.